Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Invested Capital (2016 - 2025)

Cumberland Pharmaceuticals' Return on Invested Capital history spans 15 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 11.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 11.0%, while the annual FY2025 figure was 0.05%, N/A changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.11% at Cumberland Pharmaceuticals, up from 0.12% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.1% in Q2 2021 and bottomed at 0.23% in Q3 2024.
  • The 5-year median for Return on Invested Capital is 0.16% (2022), against an average of 0.16%.
  • The largest annual shift saw Return on Invested Capital fell -13bps in 2022 before it grew 11bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.17% in 2021, then rose by 11bps to 0.15% in 2022, then decreased by -4bps to 0.16% in 2023, then crashed by -37bps to 0.22% in 2024, then skyrocketed by 49bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Return on Invested Capital are 0.11% (Q4 2025), 0.12% (Q3 2025), and 0.11% (Q2 2025).